Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

Oct 29, 2020
|
staff reporter

NEW YORK – Roche announced Thursday its Cobas EGFR Mutation Test v2 received approval from the US Food and Drug Administration of expanded claims as a companion diagnostic for non-small cell lung cancer therapies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Mouse Vision Restored

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

Side Effect Suit in India

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

Kids' Vaccine Trial Planned

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

Nature Papers Present Tool for Targeted Nanopore Sequencing, Crop Genetic Diversity, More

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis

  2. Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.